Clinical Trials Logo

Clinical Trial Summary

Primary objective: This is a descriptive study and the primary objective is to determine the incidence of injection site and systemic adverse events after Triaxis administration as a 5th dose of tetanus, diphtheria and acellular pertussis vaccine in 4-6 year old children


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01583049
Study type Observational
Source Sanofi
Contact
Status Completed
Phase N/A
Start date March 2012
Completion date August 2012

See also
  Status Clinical Trial Phase
Completed NCT01896596 - Hepatitis B Vaccination in Infants Phase 4